| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
(2,4-Difluorophenyl)-4-piperidylmethanone Oxime Hydrochloride
|
135634-18-3 |
(2,4-二氟苯基)-(4-哌啶基)甲酮肟盐酸盐
|
(2,4-Difluorophenyl)(piperidin-4-yl)methanone oxime hydrochloride;(2, 4-dp)-piperidin-4-yl-methanone oximehcl;2,4-DIFLUOROPHENYL-(4-PIPERIDINYL)METHANONE OXIME HYDROCHLORIDE;(2,4-Difluorophenyl)-4-piperidylMethanone OxiMe Hydrochloride
|
C12H15ClF2N2O |
276.71 | |
|
(2,4-Dichlorophenoxy)acetic acid
|
94-75-7 |
(2,4-二氯苯氧基)乙酸
|
2,4-滴;2,4-二氯苯氧基乙酸;2,4-二氯苯氧基乙酸/2,4-滴;2,4二氯苯氧基乙酸(2,4-D);2,4-二氟苯氧乙酸;2,4-二氯苯氧基乙酸,98%;二四滴;2,4-滴,2
|
C8H6CL2O3 |
221.04 | 202-361-1 |
|
(2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane
|
119302-24-8 |
(2b,3a,5a,16b,17b)-17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷
|
罗库溴铵杂质 I;罗库溴铵中间体2;2-(4-吗啉基)-16-(1-吡咯基)-雄甾-3-羟基-17-乙酰酯(LK-8);罗库溴铵中8;(2b,3a,5a,16b,17b)-17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷;罗库溴铵中间体 E;溴化罗库溴铵LK-8;17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷
|
C29H48N2O4 |
488.7 | 601-596-0 |
|
(2H)1,4-BENZOTHIAZIN-3(4H)-ONE
|
5325-20-2 |
(2H)1,4-苯并噻嗪-3(4H)-酮,99%
|
(2H)1,4-苯并噻嗪-3(4H)-酮,99%;1,4-苯并噻嗪-3(4H)-酮;(2H)1,4-苯并噻嗪-3(4H)-酮;2H-1,4-三嗪-3(4H)-酮;2H-1
|
C8H7NOS |
165.21 | 226-197-5 |
|
(R)-4-(tert-Butoxycarbonyl)morpholine-2-carboxylic acid
|
884512-77-0 |
(2R)-2,4-吗啉二羧酸 4-叔丁酯
|
(2R)-2,4-吗啉二羧酸 4-叔丁酯;(R)-4-BOC-吗啉-2-羧酸;(R)-N-BOC-2-吗啉甲酸;(R)-4-BOC-2-吗啉甲酸;(R)-4-(叔丁氧羰基)吗啉-2-羧酸;(2R)-4-BOC-2,4-MORPHOLINEDICARBOXYLIC ACID;(R)-N-BOC-2,4-MORPHOLINEDICARBOXYLIC ACID;(R)-4-(叔丁氧基羰基)吗啉-2-羧酸
|
C10H17NO5 |
231.25 | |
|
(R)-2-amino-3-cyclohexylpropanoic acid
|
58717-02-5 |
(2R)-2-氨基-3-环己基丙酸
|
(2R)-2-氨基-3-环己基丙酸;D-环己基丙氨酸;3-环己基-D-丙氨酸 水合物
|
C9H17NO2 |
171.24 | |
|
(R)-2-amino-N-benzyl-3-methoxypropanamide
|
196601-69-1 |
(2R)-2-氨基-3-甲氧基-N-(苯基甲基)丙酰胺
|
(2R)-2-氨基-3-甲氧基-N-(苯基甲基)丙酰胺;(R)-2-氨基-3-甲氧基-N-苄基丙酰胺;(R)-2-氨基-N-苄基-3-甲氧基丙酰胺;(2R)-2-氨基-3-苯氧基-N-苄基丙酰胺
|
C11H16N2O2 |
208.25694 | 606-353-2 |
|
(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine
|
863329-66-2 |
(2R)-2-脱氧-2-氟-2-甲基-尿苷
|
索非布韦IMP-11;(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷;2'-脱氧-2'-氟-2'-甲基脲苷;索氟布韦 中间体 SF-1;索非布韦中间体;索非布韦中间体3;(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷(索非布韦中间体);(2'R)-2'-脱氧-2'-氟-2'-
|
C10H13FN2O5 |
260.219023 | 810-481-6 |
|
Methyl α-Bromo-(2-chlorophenyl)-acetate
|
622835-93-2 |
(2R)-2-溴-2'-氯苯乙酸甲酯
|
Α-溴-2-氯苯乙酸甲酯;(2R)-2-溴-2'-氯苯乙酸甲酯
|
C9H8O2ClBr |
263.51562 | |
|
(R)-2-Bromobutanoic acid
|
2681-94-9 |
(2R)-2-溴-丁酸
|
(R)-2-BROMOBUTANOIC ACID;(R)-2-溴丁酸;2-BR-BUTYRIC ACID,(R)-2-BROMOBUTANOIC ACID,(R)-2-BROMOBUTYRIC ACID,D-2-BROMOBUTYRIC ACID,(R)-2-BROMO-BUTYRIC ACID,(R)-2-BROM-BUTTERSAEURE,D(+)-2-BROM-BUTTERSAEURE;(2R)-2-溴-丁酸
|
C4H7O2Br |
167.00118 | 145-896-5 |
|
(2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid
|
261904-39-6 |
(2R)-3-溴-2-羟基-2-甲基丙酸
|
(2R)-3-溴-2-羟基-2-甲基丙酸;(2R)-3-溴代-2-羟基-2-甲基丙酸;(R)-3-溴-2-羟基-2-甲基丙酸;(R)-3-溴-2-羟基-2-甲基丙酸
|
C4H7BrO3 |
183 | |
|
(2R)-4-BENZYL-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}MORPHOLIN-3-ONE
|
287930-75-0 |
(2R)-4-苄基-2-[(1R)-1-[3,5-双(三氟甲基)苯基]乙氧基]吗啉-3-酮
|
(2R)-4-苄基-2-[(1R)-1-[3,5-双(三氟甲基)苯基]乙氧基]吗啉-3-酮;阿瑞匹坦主链;福沙匹坦中间体;阿瑞匹坦中间体3;福沙匹坦杂质C;福沙吡坦杂质C;阿瑞匹坦杂质29;阿瑞匹坦杂质39
|
C21H19F6NO3 |
447.38 | 1312995-182-4 |
|
2H-1-Benzopyran, 6-fluoro-3,4-dihydro-2-(2R)-2-oxiranyl-, (2R)-rel-
|
876514-31-7 |
(2R)-rel-6-氟-3,4-二氢-2-(2R)-2-环氧乙烷基-2H-1-苯并吡喃
|
奈比洛尔杂质20;(2R)-REL-6-氟-3,4-二氢-2-(2R)-2-环氧乙烷基-2H-1-苯并吡喃;(2R,2'R;2S,2'S)6-氟-3,4-二氢-2H-1-苯并吡喃-2-环氧乙烷(异构体B);4-(4-(4-(4-羟苯基)-1-哌嗪基)苯基)-2-[(1S,2S)-1-乙基-2-(苄氧基)丙基]-2,4-二氢-3H-1,2,4-三唑-3-酮
|
C11H11FO2 |
618-039-2 | |
|
(R,R)-2,3-Butanediol
|
24347-58-8 |
(2R,3R)-(-)-2,3-丁二醇
|
(2R,3R)-(-)-2,3-丁二醇,98%;(R,R)-(-)-2,3-丁二醇(>96.0%(GC));3-丁烯二醇;(R,3-丁二醇 1KG;(2R,3-丁二醇;(D)-(-)-2,3-丁二醇;D(-)-2,3-丁二醇;(R
|
C4H10O2 |
90.12 | 246-186-9 |
|
1-[(2R,3R)-2-(2,4-difluorophenyl)-2,3-dihydroxybutyl]-1H-[1,2,4]triazole methanesulfonate salt
|
1175536-50-1 |
(2R,3R)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2,3-丁二醇甲烷磺酸盐
|
艾氟康唑中间体2;EP-F;(2R,3R)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2,3-丁二醇甲烷磺酸盐;(2R,4-三唑-1-基)丁烷-2,3-二醇甲磺酸盐
|
C13H15F2N3O4S |
347.337706 | 815-196-0 |
|
Efinaconazole Impurity 1
|
133775-25-4 |
(2R,3R)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)丁烷-2,3-二醇
|
(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol;(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol;Efinaconazole intermediate;(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3;2,3-Butanediol, 2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (2R,3R)-;(2R,3R)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butane-2,3-diol
|
|||
|
2R,3R)-3-(3-Methoxyphenyl)-N,N,2-trimethylpentan-1-amine
|
175591-22-7 |
(2R,3R)-3-(3-甲氧基苯基)-N,N,2-三甲基戊胺
|
(2R,3R)-3-(3-甲氧基苯基)-N,N,2-三甲基戊胺;他喷他多中间体
|
C15H25NO |
235.3651 | |
|
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-[4-chloro-3-(4-ethoxybenzyl)phenyl]tetrahydropyran-3,4,5-triyl Triacetate
|
461432-25-7 |
(2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-乙氧基苄基)苯基)四氢-2H-吡喃-3,4,5-三YL 三乙酸酯
|
(2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-乙氧基苄基)苯基)四氢-2H-吡喃-3,4,5-三YL 三乙酸酯;(1S)-1,5-脱水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-山梨醇四乙酸酯;达格列净-脱甲氧基产物中间体;达格列净中间体1;(1S)-1,5-脱水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-山梨醇四乙酸酯(达格列净中间体4);达格列净中间体IV;达格列净杂质26;乙酰达格列净
|
C29H33ClO10 |
577.01932 | 930-010-9 |
|
(2R,3S)-tert-Butyl 6-oxo-2,3-diphenylmorpholine-4-carboxylate
|
112741-49-8 |
(2R,3S)- N-叔丁氧羰基-2,3-二苯基吗啉-6-酮
|
(5R,6S)-N-叔丁氧羰基-5,6-二苯基吗啉-2-酮;(2R,3S)-2,3-二苯基-6-氧代吗啉-4-甲酸叔丁酯;(2R,3S)-(-)-6-氧代-二苯基-4-吗啉甲酸叔丁酯;(5S,6R)-N-BOC-5,6-二苯基-2-吗啉酮;(2R,3S)-(-)-N-BOC-2,3-二苯基-6-氧代吗啉;(2R,3S)-(-)-N-叔丁氧羰基-6-氧代-2,3-二苯基吗啉;(5R,6S)-(-)-4-BOC-5,3S)-(-)-6-氧代-2,3-二苯基-4-吗啉羧酸叔丁酯
|
C21H23NO4 |
353.41 | |
|
(2R,3S)-2-[(1R)-1-[3,5-bis(Trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)morpholine
|
171338-27-5 |
(2R,3S)-2-[(1R)-1-[3,5-双(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)吗啉
|
(2R,3S)-2-[(1R)-1-[3,5-双(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)吗啉;福沙匹坦杂质D;福沙吡坦杂质D;福沙匹坦中间体4
|
C20H18F7NO2 |
437.35 |
药智官方微信
药智官方微博
